Detalles de la búsqueda
1.
Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer.
Cancer Immunol Immunother
; 72(12): 4089-4102, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801126
2.
NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development.
Nucleic Acids Res
; 49(10): 5760-5778, 2021 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34037780
3.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(2): 234-247, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030335
4.
A new KSRP-binding compound suppresses distant metastasis of colorectal cancer by targeting the oncogenic KITENIN complex.
Mol Cancer
; 20(1): 78, 2021 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039363
5.
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial).
Gastric Cancer
; 24(1): 156-167, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32596783
6.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(8): 1045-1056, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682457
7.
Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.
Cancer Sci
; 111(9): 3268-3278, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533590
8.
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Cancer
; 126(20): 4521-4531, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749686
9.
ErbB4/KITENIN-Mediated Signaling is Activated in Cetuximab-Resistant Colorectal Cancer Cells.
J Nanosci Nanotechnol
; 19(2): 1166-1171, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360226
10.
Prevalence and predictors of major depressive disorder in bereaved caregivers at 6 and 13 months.
Palliat Support Care
; 17(3): 300-305, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29806573
11.
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.
Eur J Nucl Med Mol Imaging
; 45(2): 170-178, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28940101
12.
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Oncologist
; 22(3): 293-303, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209749
13.
KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
Mol Carcinog
; 56(3): 1068-1081, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27648936
14.
Self-Administered Tinnitus Pitch Matching versus a Conventional Audiometric Procedure.
Audiol Neurootol
; 22(1): 1-8, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28423381
15.
Influence of caregiver personality on the burden of family caregivers of terminally ill cancer patients.
Palliat Support Care
; 14(1): 5-12, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25881585
16.
The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.
Mol Carcinog
; 54(10): 1172-80, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043748
17.
Differential Associations Between Delirium and Mortality According to Delirium Subtype and Age: A Prospective Cohort Study.
Psychosom Med
; 77(8): 903-10, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26397939
18.
SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
BMC Cancer
; 15: 888, 2015 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26555193
19.
Discordance among patient preferences, caregiver preferences, and caregiver predictions of patient preferences regarding disclosure of terminal status and end-of-life choices.
Psychooncology
; 24(2): 212-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25099223
20.
Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists.
Psychooncology
; 24(11): 1398-406, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25970704